Ligand validation:8SSP

627: N-[(3E)-5-[(2R)-2-METHOXY-2-PHENYLACETYL]PYRROLO[3,4-C]PYRAZOL-3(5H)-YLIDENE]-4-(4-METHYLPIPERAZIN-1-YL)BENZAMIDE

627 is a Ligand Of Interest in 8SSP designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
8SSP_627_A_510	68%	48%	0.148	0.961	0.68	1.32	-	6	0	0	100%	1
8SSO_627_A_503	85%	43%	0.102	0.967	0.66	1.54	-	6	0	0	100%	1
2J50_627_B_1390	41%	13%	0.232	0.949	2.32	1.64	15	8	3	0	100%	1
5I9Z_627_A_1001	92%	22%	0.071	0.961	2.15	1.09	5	4	0	0	100%	1
4QO9_627_A_404	81%	1%	0.103	0.954	6.43	1.54	17	5	0	0	100%	1
2V7A_627_B_1504	70%	11%	0.129	0.948	2.34	1.85	5	6	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.